Rydex Biotechnology Fund Investor (RYOIX)
76.45
+0.94
(+1.24%)
USD |
Dec 22 2025
RYOIX Asset Allocations & Exposures
Asset Allocation
As of November 30, 2025.
| Type | % Net |
|---|---|
| Cash | 0.90% |
| Stock | 99.18% |
| Bond | 0.00% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | -0.09% |
Market Capitalization
As of November 30, 2025
| Large | 33.30% |
| Mid | 18.67% |
| Small | 48.03% |
Region Exposure
| Americas | 87.86% |
|---|---|
|
North America
|
87.86% |
| United States | 87.86% |
|
Latin America
|
0.00% |
As of November 30, 2025. Region breakdown data is
calculated by using the long position holdings of the portfolio.
| Greater Europe | 11.33% |
|---|---|
| United Kingdom | 3.35% |
|
Europe Developed
|
7.98% |
| Denmark | 0.48% |
| Germany | 0.94% |
| Ireland | 2.58% |
| Netherlands | 1.37% |
| Switzerland | 2.60% |
|
Europe Emerging
|
0.00% |
|
Africa And Middle East
|
0.00% |
| Greater Asia | 0.00% |
|---|---|
| Japan | 0.00% |
|
Australasia
|
0.00% |
|
Asia Developed
|
0.00% |
|
Asia Emerging
|
0.00% |
| Unidentified Region | 0.82% |
|---|
Stock Sector Exposure
| Cyclical |
|
2.38% |
| Materials |
|
2.38% |
| Consumer Discretionary |
|
0.00% |
| Financials |
|
0.00% |
| Real Estate |
|
0.00% |
| Sensitive |
|
0.00% |
| Communication Services |
|
0.00% |
| Energy |
|
0.00% |
| Industrials |
|
0.00% |
| Information Technology |
|
0.00% |
| Defensive |
|
97.62% |
| Consumer Staples |
|
0.00% |
| Health Care |
|
97.62% |
| Utilities |
|
0.00% |
| Not Classified |
|
0.00% |
| Non Classified Equity |
|
0.00% |
| Not Classified - Non Equity |
|
0.00% |
As of November 30, 2025
Stock Style Exposure
| Large Cap Value | -- |
| Large Cap Core | -- |
| Large Cap Growth | -- |
| Mid Cap Value | -- |
| Mid Cap Core | -- |
| Mid Cap Growth | -- |
| Small Cap Value | -- |
| Small Cap Core | -- |
| Small Cap Growth | -- |